Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
about
Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cellsDefining the region(s) of deletion at 6q16-q22 in human prostate cancer.Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH dataCo-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancerMinimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.DNA methylation changes in prostate cancer: current developments and future clinical implementation.High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays.Expression of DDX27 contributes to colony-forming ability of gastric cancer cells and correlates with poor prognosis in gastric cancer.Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.Distinct genomic aberrations associated with ERG rearranged prostate cancerThe evolving role of familial history for prostate cancer.High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancerMeta-analyses of methylation markers for prostate cancer.NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.Statistical dissection of genetic pathways involved in prostate carcinogenesis.Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis.DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.ADRM1 gene amplification is a candidate driver for metastatic gastric cancers.Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis.
P2860
Q27324165-E701BE60-E5AE-48C2-A1C8-8B7B6B47F4A2Q30309336-AEE5D506-B94F-4346-8E08-D56AB33E948CQ31074064-BC21706A-055F-40BE-8CE3-08A3D2FE1F39Q31140388-00309680-FD13-49F3-B576-801B628F2482Q33381372-03FA3872-5981-431C-AF70-663EB209D191Q33415599-6421CB76-B77E-4DB9-91BD-352FDF08F4F7Q33812864-227BAD0B-599F-40EA-8496-0320707660C1Q34320113-62760266-FE65-4CFE-8735-50CF85094A2FQ35000853-6C8D50C0-ED83-486B-8949-306DEB479756Q35636543-446711D5-4B09-4A1E-B7B2-92EFA04B523DQ35791403-C372091D-1B32-4D85-9617-93DA08084132Q36309375-0F5CCDEE-073C-45BE-9666-2678DE4F6424Q36610469-BF9E0877-A98F-42A5-9F5C-CA2F3B152564Q37173727-91FCD4CA-5B39-49CA-A486-721D5D4A2CDAQ37793100-DF9DA84E-4516-4991-A63D-1A3D32DA7949Q38441193-E0A00F5A-EB1A-47A3-B335-3A5B4C747443Q38996065-3A1F4BA8-E8BB-47D9-AAC1-71871F1E6375Q39155363-97C44885-4DEF-4EF8-BEB9-7375C9491F4FQ40073572-9488305E-8520-46F4-9A1B-022A6A422B0AQ40622027-AAEFF468-667A-4EC5-BC64-39814476C2DEQ42671173-E81EAE4A-5A58-43A7-B5EA-4D59871276E3Q47254420-DDEF17CB-43B4-4440-9865-C3FD8D890311Q48081055-56ADF7B6-4C17-489C-9BDD-7854D27A4B80Q48487053-89E1005D-DA18-454F-8405-527A2201F488Q50205669-97DA100B-7C51-4DCF-9B73-653EB7610451Q53038879-2B78439C-C3E8-45A9-8C5F-F7FB89518C99Q54105608-E143E097-375D-45A2-B660-85880B105A43
P2860
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Molecular cytogenetic analysis ...... n aggressive genetic features.
@en
Molecular cytogenetic analysis ...... n aggressive genetic features.
@nl
type
label
Molecular cytogenetic analysis ...... n aggressive genetic features.
@en
Molecular cytogenetic analysis ...... n aggressive genetic features.
@nl
prefLabel
Molecular cytogenetic analysis ...... n aggressive genetic features.
@en
Molecular cytogenetic analysis ...... n aggressive genetic features.
@nl
P2093
P2860
P1476
Molecular cytogenetic analysis ...... n aggressive genetic features.
@en
P2093
F H Schröder
H van Dekken
M F Wildhagen
P J Krijtenburg
R F Hoedemaeker
T T van Der Kwast
P2860
P304
P356
10.1016/S0002-9440(10)63983-1
P407
P577
2001-02-01T00:00:00Z